Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
The findings, published online today in Nature, describe not only a way to detect cancer, but hold promise of being able to find it earlier when it is more easily treated and long before symptoms ever appear, says Dr. De Carvalho, Senior Scientist at the cancer centre, University Health Network.
“We are very excited at this stage,” says Dr. De Carvalho. “A major problem in cancer is how to detect it early. It has been a ‘needle in the haystack’ problem of how to find that one-in-a-billion cancer-specific mutation in the blood, especially at earlier stages, where the amount of tumour DNA in the blood is minimal.”
By profiling epigenetic alterations instead of mutations, the team was able to identify thousands of modifications unique to each cancer type. Then, using a big data approach, they applied machine learning to create classifiers able to identify the presence of cancer-derived DNA within blood samples and to determine what cancer type. This basically turns the “one needle in the haystack” problem into a more solvable “thousands of needles in the haystack,” where the computer just needs to find a few needles to define which haystack has needles.
The scientists tracked the cancer origin and type by comparing 300 patient tumour samples from seven disease sites (lung, pancreatic, colorectal, breast, leukemia, bladder and kidney) and samples from healthy donors with the analysis of cell-free DNA circulating in the blood plasma. In every sample, the “floating” plasma DNA matched the tumour DNA. The team has since expanded the research and has now profiled and successfully matched more than 700 tumour and blood samples from more cancer types.
Beyond the lab, next steps to further validate this approach include analysing data from large population health research studies already under way in several countries, where blood samples were collected months to years before cancer diagnosis. Then the approach will need to be ultimately validated in prospective studies for cancer screening.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Blood Cancer Drugs Market World Approaching Demand and Growth Prospect 2019 to 2025on October 17, 2019 at 11:33 am
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important ...
- Breast Cancer Scare for Beyoncé’s Dadon October 17, 2019 at 7:34 am
I immediately called my doctor." An inconclusive blood smear test lead to a mammogram which showed that he had stage 1A breast cancer. He underwent a mastectomy and had three lymph nodes removed, ...
- Global Uterine Cancer Diagnostics Testing Market to Witness Remarkable Growth on Account of Improving Healthcare Facilitieson October 17, 2019 at 3:54 am
The study is titled,” Uterine Cancer Diagnostics Testing Market Size, Share and Global Trend by Type (Blood test, Endometrial biopsy, Imaging, Others), By End-user (Hospitals, Diagnostic centers, ...
- MGH doctors diagnose, monitor brain cancer by turning blood cells florescent pinkon October 15, 2019 at 3:20 pm
Scientists found that brain cancer cells also become florescent in the presence of 5-ALA, meaning blood tests using the substance might be useful for diagnosing the cancer and monitoring patients for ...
- Glowing particles in the blood may help diagnose and monitor brain canceron October 15, 2019 at 11:03 am
... called extracellular vesicles (EVs), investigators wondered whether EVs in the blood of patients with brain cancer might turn fluorescent pink when they drink 5-ALA, just as their brain tumors do.
- AI Detects Brain Cancer from a Blood Teston October 14, 2019 at 4:51 pm
In June 2016, the first liquid biopsy test approved for use by the U.S. Food and Drug ... field of IR spectroscopy as well as the clinical environment. Analysis of blood serum using this technique ...
- New blood test detects brain tumors with 87% accuracyon October 11, 2019 at 5:07 pm
A new blood test that can detect brain cancer has been developed in the United Kingdom. It’s cutting edge technology uses artificial intelligence and has a high accuracy rate.
- Blood Test to Diagnose Brain Cancer in Developmenton October 11, 2019 at 5:25 am
Brain cancer remains challenging to diagnose, due to non-specific symptoms and a lack of cost-effective tests. A new blood test that uses attenuated total reflection (ATR)-Fourier transform infrared ...
- New Thyroid Cancer Test Reduces Unnecessary Surgerieson October 10, 2019 at 10:48 pm
It plays an important role in the body, supporting the endocrine system and the production of hormones that control metabolic rate, heart rate, body temperature and blood pressure. To create the new ...
via Bing News